Colorectal

Investigating Ipi/Nivo With Panitumumab in MSS mCRC
Dr. Ashwin Somasundaram discusses the results of a recent phase 2 study of ipilimumab, nivolumab, and panitumumab for mCRC.
Advertisement

Roundtable Discussions

Knowledge Hubs

Colorectal
Advertisement
Section Editor

Advertisement
Latest GI Oncology News

April 15, 2025